Sophie Carter

732 total citations
18 papers, 541 citations indexed

About

Sophie Carter is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Sophie Carter has authored 18 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Physiology and 5 papers in Epidemiology. Recurrent topics in Sophie Carter's work include Adipose Tissue and Metabolism (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and CRISPR and Genetic Engineering (5 papers). Sophie Carter is often cited by papers focused on Adipose Tissue and Metabolism (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and CRISPR and Genetic Engineering (5 papers). Sophie Carter collaborates with scholars based in Canada, France and United States. Sophie Carter's co-authors include Frédéric Picard, Alexandre Caron, Denis Richard, Yannick Doyon, Stéphanie Miard, Jérémy Loehr, Daniel Agudelo, Yves Deshaies, Caroline Huard and Jayme Salsman and has published in prestigious journals such as PLoS ONE, Nature Methods and Diabetes.

In The Last Decade

Sophie Carter

16 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Carter Canada 11 265 148 124 93 81 18 541
Yumiko Takei Japan 7 190 0.7× 101 0.7× 100 0.8× 84 0.9× 16 0.2× 12 474
Steven M. Bauer United States 6 393 1.5× 188 1.3× 186 1.5× 67 0.7× 20 0.2× 13 644
Nicole Hamers Netherlands 14 308 1.2× 221 1.5× 191 1.5× 38 0.4× 24 0.3× 18 674
Neus Pueyo Spain 9 349 1.3× 130 0.9× 95 0.8× 43 0.5× 37 0.5× 9 628
Kelly Hester United States 10 258 1.0× 148 1.0× 193 1.6× 29 0.3× 19 0.2× 23 536
Angelika Jurdzinski Netherlands 10 323 1.2× 73 0.5× 119 1.0× 36 0.4× 26 0.3× 19 598
Andrew R. Haynes United Kingdom 7 468 1.8× 124 0.8× 82 0.7× 32 0.3× 14 0.2× 10 720
Sofía Cabezudo Spain 8 248 0.9× 94 0.6× 65 0.5× 36 0.4× 23 0.3× 9 452
Kennedy Makondo Japan 13 244 0.9× 102 0.7× 73 0.6× 19 0.2× 24 0.3× 19 557
Turid Frahnow Germany 7 185 0.7× 176 1.2× 185 1.5× 15 0.2× 25 0.3× 10 519

Countries citing papers authored by Sophie Carter

Since Specialization
Citations

This map shows the geographic impact of Sophie Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Carter more than expected).

Fields of papers citing papers by Sophie Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Carter. The network helps show where Sophie Carter may publish in the future.

Co-authorship network of co-authors of Sophie Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Carter. A scholar is included among the top collaborators of Sophie Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Carter. Sophie Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Harvey, Kate, et al.. (2021). 750 Learning disability – how confident are we to make the diagnosis?. Abstracts. A103.1–A103.
3.
Agudelo, Daniel, Sophie Carter, Sébastien Levesque, et al.. (2020). Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9. Genome Research. 30(1). 107–117. 54 indexed citations
4.
Carter, Sophie, Isabelle Lemieux, Zhuo Li, et al.. (2018). Changes in IGFBP-2 levels following a one-year lifestyle modification program are independently related to improvements in plasma apo B and LDL apo B levels. Atherosclerosis. 281. 89–97. 10 indexed citations
5.
Carter, Sophie, et al.. (2018). Loss of Malat1 does not modify age- or diet-induced adipose tissue accretion and insulin resistance in mice. PLoS ONE. 13(5). e0196603–e0196603. 13 indexed citations
6.
Carter, Sophie, Stéphanie Miard, Alexandre Caron, et al.. (2018). Loss of OcaB Prevents Age-Induced Fat Accretion and Insulin Resistance by Altering B-Lymphocyte Transition and Promoting Energy Expenditure. Diabetes. 67(7). 1285–1296. 28 indexed citations
7.
Miard, Stéphanie, Philippe Joubert, Sophie Carter, et al.. (2017). Absence of Malat1 does not prevent DEN-induced hepatocarcinoma in mice. Oncology Reports. 37(4). 2153–2160. 9 indexed citations
8.
Caron, Alexandre, Sébastien M. Labbé, Sophie Carter, et al.. (2017). Loss of UCP2 impairs cold-induced non-shivering thermogenesis by promoting a shift toward glucose utilization in brown adipose tissue. Biochimie. 134. 118–126. 29 indexed citations
9.
Agudelo, Daniel, Lusiné Bozoyan, Caroline Huard, et al.. (2017). Marker-free coselection for CRISPR-driven genome editing in human cells. Nature Methods. 14(6). 615–620. 110 indexed citations
10.
Carter, Sophie & Yannick Doyon. (2017). Gene Therapy in Tyrosinemia: Potential and Pitfalls. Advances in experimental medicine and biology. 959. 231–243. 4 indexed citations
11.
Agudelo, Daniel, Lusiné Bozoyan, Caroline Huard, et al.. (2017). A marker-free co-selection strategy for high efficiency homology-driven and NHEJ-based gene editing in human cells. Protocol Exchange. 1 indexed citations
12.
Carter, Sophie, Richard Draijer, Sophie M. Holder, Dick H. J. Thijssen, & Nicola D. Hopkins. (2016). The effect of breaking up prolonged sitting on cerebral blood flow. Research at York St John (York St John University). 1 indexed citations
13.
Carter, Sophie, Romain Capoulade, Marie Arsenault, et al.. (2015). Relationship Between Insulin-Like Growth Factor Binding Protein-2 and Left Ventricular Stroke Volume in Patients With Aortic Stenosis. Canadian Journal of Cardiology. 31(12). 1447–1454. 7 indexed citations
14.
Carter, Sophie, Zhuo Li, Isabelle Lemieux, et al.. (2014). Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides. Atherosclerosis. 237(2). 645–651. 40 indexed citations
15.
Picard, Frédéric, Sophie Carter, Alexandre Caron, & Denis Richard. (2013). Role of leptin resistance in the development of obesity in older patients. Clinical Interventions in Aging. 8. 829–829. 94 indexed citations
16.
Meloche, Jolyane, Marjorie Barrier, Sophie Carter, et al.. (2013). Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology. Journal of the American Heart Association. 2(1). e005157–e005157. 87 indexed citations
17.
Carter, Sophie, Stéphanie Miard, Zhuo Li, et al.. (2012). Sirt1 Inhibits Resistin Expression in Aortic Stenosis. PLoS ONE. 7(4). e35110–e35110. 19 indexed citations
18.
Miard, Stéphanie, et al.. (2009). Aging alters PPARγ in rodent and human adipose tissue by modulating the balance in steroid receptor coactivator‐1. Aging Cell. 8(4). 449–459. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026